50242-0132 Herceptin - CanMED: NDC

Product NDC:

50242-0132

Brand Name:

Herceptin

Generic Name:

Trastuzumab

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: Trastuzumab

Strength: 150.0

Unit: mg/7.4mL

Packages:

Code: 50242-0132-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-132-01) / 15 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Feb. 10, 2017

Discontinued:

Code: 50242-0132-10

Description: 10 VIAL, SINGLE-DOSE in 1 CARTON (50242-132-10) / 15 mL in 1 VIAL, SINGLE-DOSE

Effective Date: June 3, 2019

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox